We recently published a list of the 12 Best Dividend Kings to Buy For Safe Dividend Growth. In this article, we are going to ...

Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 ...

Abbott Laboratories closed 6.08% below its 52-week high of $141.23, which the company reached on March 4th.

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

We recently published a list of the 8 Most Profitable Dividend Stocks to Buy Now. In this article, we are going to take a ...

Valued at a market cap of $228.3 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells healthcare products. The company operates in ...

We recently published a list of Diamond Hill Capital Stock Portfolio: Top 10 Stock Picks. In this article, we are going to ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

But there’s a powerful fundamental story happening with Abbott Laboratories. Also, EPS is estimated to ramp higher this year by +10.8%. Now it makes sense why the stock has been powering to new ...

Abbott (ABT) announced late-breaking data from its Triluminate Pivotal trial that show the TriClip transcatheter edge-to-edge repair system to ...

Abbott Laboratories closed 11.07% short of its 52-week high of $141.23, which the company achieved on March 4th.

It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, when its stock has declined 9.6% over the past month. However, stock prices are usually driven by a ...